Antihypertensive drug (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antihypertensive drug" in English language version.

refsWebsite

Global rank English rank

85nih.gov

4^th place

57doi.org

2^nd place

17semanticscholar.org

11^th place

8^th place

10web.archive.org

1^st place

3nice.org.uk

3,258^th place

2,666^th place

2handle.net

102^nd place

76^th place

1australianprescriber.com

low place

1sciencedirect.com

149^th place

178^th place

1mayoclinic.org

1,610^th place

1,279^th place

1nelm.nhs.uk

low place

1pharmaxchange.info

low place

7,837^th place

1uq.edu.au

3,558^th place

2,403^rd place

1umaryland.edu

low place

7,717^th place

1lecturio.com

5,619^th place

2,948^th place

1merck.com

6,464^th place

5,671^st place

1nihr.ac.uk

low place

6,693^rd place

australianprescriber.com

Nelson M. "Drug treatment of elevated blood pressure". Australian Prescriber (33): 108–112. Archived from the original on 26 August 2010. Retrieved August 11, 2010.

doi.org

Law M, Wald N, Morris J (2003). "Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy". Health Technology Assessment. 7 (31): 1–94. doi:10.3310/hta7310. PMID 14604498.
Nelson MR, McNeil JJ, Peeters A, Reid CM, Krum H (June 2001). "PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998". The Medical Journal of Australia. 174 (11): 565–8. doi:10.5694/j.1326-5377.2001.tb143436.x. PMID 11453328. S2CID 204078909.
Wright JM, Musini VM, Gill R (April 2018). Wright JM (ed.). "First-line drugs for hypertension". The Cochrane Database of Systematic Reviews. 2018 (4): CD001841. doi:10.1002/14651858.CD001841.pub3. PMC 6513559. PMID 29667175.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. (February 2014). "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID 24352797.
Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL (August 2006). "Thiazide diuretics, potassium, and the development of diabetes: a quantitative review". Hypertension. 48 (2): 219–24. doi:10.1161/01.HYP.0000231552.10054.aa. PMID 16801488.
Wang TJ, Ausiello JC, Stafford RS (April 1999). "Trends in antihypertensive drug advertising, 1985-1996". Circulation. 99 (15): 2055–7. doi:10.1161/01.CIR.99.15.2055. PMID 10209012.
Heran BS, Chen JM, Wang JJ, Wright JM, et al. (Cochrane Hypertension Group) (November 2012). "Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension". The Cochrane Database of Systematic Reviews. 11: CD008167. doi:10.1002/14651858.CD008167.pub3. PMID 23152254.
Elliott WJ, Ram CV (September 2011). "Calcium channel blockers". Journal of Clinical Hypertension. 13 (9): 687–689. doi:10.1111/j.1751-7176.2011.00513.x. PMC 8108866. PMID 21896151.
Bakris GL, Weir MR, Secic M, Campbell B, Weis-McNulty A (June 2004). "Differential effects of calcium antagonist subclasses on markers of nephropathy progression". Kidney International. 65 (6): 1991–2002. doi:10.1111/j.1523-1755.2004.00620.x. PMID 15149313.
Spiller HA (January 2005). "ACE Inhibitors". In Wexler P (ed.). Encyclopedia of Toxicology (Second ed.). New York: Elsevier. pp. 9–11. doi:10.1016/b0-12-369400-0/00006-5. ISBN 978-0-12-369400-3. Retrieved 2024-03-13.
Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, et al. (October 2013). "Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis". BMJ. 347: f6008. doi:10.1136/bmj.f6008. PMC 3807847. PMID 24157497.
Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. (November 2002). "Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial". JAMA. 288 (19): 2421–31. doi:10.1001/jama.288.19.2421. PMID 12435255.
Furberg CD, Wright Jr JT, Davis BR, Cutler JA, Alderman M, Black H, et al. (The Allhat Officers And Coordinators For The Allhat Collaborative Research Group) (December 2002). "Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)". JAMA. 288 (23): 2981–97. doi:10.1001/jama.288.23.2981. PMID 12479763.
Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, et al. (September 2006). "Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial". Hypertension. 48 (3): 374–84. doi:10.1161/01.HYP.0000231662.77359.de. PMID 16864749.
Borghi C, Soldati M, Bragagni A, Cicero AF (December 2020). "Safety implications of combining ACE inhibitors with thiazides for the treatment of hypertensive patients". Expert Opinion on Drug Safety. 19 (12): 1577–1583. doi:10.1080/14740338.2020.1836151. PMID 33047990. S2CID 222320206.
Barreras A, Gurk-Turner C (January 2003). "Angiotensin II receptor blockers". Proceedings. 16 (1): 123–126. doi:10.1080/08998280.2003.11927893. PMC 1200815. PMID 16278727.
Verma S, Strauss M (November 2004). "Angiotensin receptor blockers and myocardial infarction". BMJ. 329 (7477): 1248–9. doi:10.1136/bmj.329.7477.1248. PMC 534428. PMID 15564232.
Strauss MH, Hall AS (August 2006). "Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox". Circulation. 114 (8): 838–54. doi:10.1161/CIRCULATIONAHA.105.594986. PMID 16923768.
Tsuyuki RT, McDonald MA (August 2006). "Angiotensin receptor blockers do not increase risk of myocardial infarction". Circulation. 114 (8): 855–60. doi:10.1161/CIRCULATIONAHA.105.594978. PMID 16923769.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. (June 2004). "Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial". Lancet. 363 (9426): 2022–31. doi:10.1016/S0140-6736(04)16451-9. hdl:11392/462725. PMID 15207952. S2CID 19111421.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, et al. (September 2003). "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial". Lancet. 362 (9386): 772–6. doi:10.1016/S0140-6736(03)14284-5. PMID 13678870. S2CID 5650345.
Levy BI (September 2005). "How to explain the differences between renin angiotensin system modulators". American Journal of Hypertension. 18 (9 Pt 2): 134S–141S. doi:10.1016/j.amjhyper.2005.05.005. PMID 16125050.
Lévy BI (January 2004). "Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system". Circulation. 109 (1): 8–13. doi:10.1161/01.CIR.0000096609.73772.C5. PMID 14707017.
Reudelhuber TL (December 2005). "The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous". Hypertension. 46 (6): 1261–2. doi:10.1161/01.HYP.0000193498.07087.83. PMID 16286568.
Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN (August 1991). "Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure". The New England Journal of Medicine. 325 (5): 293–302. doi:10.1056/nejm199108013250501. PMID 2057034.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. (September 2016). "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America". Circulation. 134 (13): e282-93. doi:10.1161/CIR.0000000000000435. PMID 27208050.
Li EC, Heran BS, Wright JM (August 2014). "Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension". The Cochrane Database of Systematic Reviews. 2014 (8): CD009096. doi:10.1002/14651858.CD009096.pub2. PMC 6486121. PMID 25148386.
Lindholm LH, Carlberg B, Samuelsson O (29 Oct – 4 Nov 2005). "Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis". Lancet. 366 (9496): 1545–53. doi:10.1016/S0140-6736(05)67573-3. PMID 16257341. S2CID 34364430.
Carlberg B, Samuelsson O, Lindholm LH (6–12 Nov 2004). "Atenolol in hypertension: is it a wise choice?". Lancet. 364 (9446): 1684–9. doi:10.1016/S0140-6736(04)17355-8. PMID 15530629. S2CID 23759357.
Freemantle N, Cleland J, Young P, Mason J, Harrison J (June 1999). "beta Blockade after myocardial infarction: systematic review and meta regression analysis". BMJ. 318 (7200): 1730–7. doi:10.1136/bmj.318.7200.1730. PMC 31101. PMID 10381708.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (September 2003). "Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)". Hypertension. 42 (3): 239–46. doi:10.1161/01.HYP.0000086521.95630.5A. PMID 12925554.
Varon J, Marik PE (July 2000). "The diagnosis and management of hypertensive crises". Chest. 118 (1): 214–27. doi:10.1378/chest.118.1.214. PMID 10893382.
Craft J (April 2004). "Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure". Proceedings. 17 (2): 217–220. doi:10.1080/08998280.2004.11927973. PMC 1200656. PMID 16200104.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. (May 2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.
Giovannitti JA, Thoms SM, Crawford JJ (2015). "Alpha-2 adrenergic receptor agonists: a review of current clinical applications". Anesthesia Progress. 62 (1): 31–39. doi:10.2344/0003-3006-62.1.31. PMC 4389556. PMID 25849473.
Valerio CJ, Coghlan JG (August 2009). "Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient". Vascular Health and Risk Management. 5: 607–619. doi:10.2147/VHRM.S4713. PMC 2725793. PMID 19688101.
Neurath Jr HM, Goldman AI, Lavin MA, Schnaper HW, Fitz AE, Frohlich ED, et al. (Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension) (1978). "Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension". Annals of the New York Academy of Sciences. 304: 267–292. doi:10.1111/j.1749-6632.1978.tb25604.x. PMID 360921. S2CID 40939559.
Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. (February 2003). "A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly" (PDF). The New England Journal of Medicine. 348 (7): 583–92. doi:10.1056/NEJMoa021716. hdl:2440/4230. PMID 12584366.
Whelton PK, Williams B (November 2018). "The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: More Similar Than Different". JAMA. 320 (17): 1749–1750. doi:10.1001/jama.2018.16755. PMID 30398611. S2CID 53207044.
Lewis PJ, Kohner EM, Petrie A, Dollery CT (March 1976). "Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment". Lancet. 1 (7959): 564–6. doi:10.1016/S0140-6736(76)90359-7. PMID 55840. S2CID 20976708.
Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT (December 1982). "Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up". Lancet. 2 (8311): 1293–5. doi:10.1016/S0140-6736(82)91506-9. PMID 6128594. S2CID 43027989.
Messerli FH, Williams B, Ritz E (August 2007). "Essential hypertension". Lancet. 370 (9587): 591–603. doi:10.1016/S0140-6736(07)61299-9. PMID 17707755. S2CID 26414121.
Williams B (November 2003). "Treatment of hypertension in the UK: simple as ABCD?". Journal of the Royal Society of Medicine. 96 (11): 521–2. doi:10.1177/014107680309601101. PMC 539621. PMID 14594956.
Parekh N, Page A, Ali K, Davies K, Rajkumar C (April 2017). "A practical approach to the pharmacological management of hypertension in older people". Therapeutic Advances in Drug Safety. 8 (4): 117–132. doi:10.1177/2042098616682721. PMC 5394506. PMID 28439398.
Tatu AL, Elisei AM, Chioncel V, Miulescu M, Nwabudike LC (August 2019). "Immunologic adverse reactions of β-blockers and the skin". Experimental and Therapeutic Medicine. 18 (2): 955–959. doi:10.3892/etm.2019.7504. PMC 6639944. PMID 31384329. S2CID 145847997.
Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C (October 2016). "Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel". Internal Medicine Journal. 46 (10): 1189–1197. doi:10.1111/imj.13215. PMC 5129475. PMID 27527376.
Würzner G, Gerster JC, Chiolero A, Maillard M, Fallab-Stubi CL, Brunner HR, et al. (October 2001). "Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout". Journal of Hypertension. 19 (10): 1855–1860. doi:10.1097/00004872-200110000-00021. PMID 11593107. S2CID 20842819.
Worcester EM, Coe FL: Clinical practice. Calcium kidney stones" N Engl J Med 2010;363(10) 954-963. Worcester EM, Coe FL (September 2010). "Clinical practice. Calcium kidney stones". The New England Journal of Medicine. 363 (10): 954–63. doi:10.1056/NEJMcp1001011. PMC 3192488. PMID 20818905.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. (May 2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report" (PDF). JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Archived (PDF) from the original on 2013-02-16. Retrieved 2013-02-17.
Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL, et al. (May 2007). "Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention". Circulation. 115 (21): 2761–88. doi:10.1161/circulationaha.107.183885. PMID 17502569.
Pietropaoli D, Del Pinto R, Ferri C, Wright JT, Giannoni M, Ortu E, et al. (December 2018). "Poor Oral Health and Blood Pressure Control Among US Hypertensive Adults". Hypertension. 72 (6): 1365–1373. doi:10.1161/HYPERTENSIONAHA.118.11528. PMID 30540406.
Papadopoulou Z, Tsialiou TM, Styanidou FE, Kavvadas D, Papamitsou T (December 2021). "In Utero Exposure to Antihypertensive Medication during the First Trimester: Is the Risk Worth Taking?". Acta Medica Academica. 50 (3): 372–381. doi:10.5644/ama2006-124.356. PMID 35164513. S2CID 246826268.
"Decision aid helps pregnant women with high blood pressure". NIHR Evidence. 15 February 2023. doi:10.3310/nihrevidence_56796. S2CID 257843687.
Whybrow R, Sandall J, Girling J, Brown H, Seed PT, Green M, et al. (December 2022). "Implementation of a novel shared decision-making intervention in women with chronic hypertension in pregnancy: multiple-site multiple-method investigation". Pregnancy Hypertension. 30: 137–144. doi:10.1016/j.preghy.2022.09.007. PMID 36194966. S2CID 252414448.
Godfraind T (2017-05-29). "Discovery and Development of Calcium Channel Blockers". Frontiers in Pharmacology. 8: 286. doi:10.3389/fphar.2017.00286. PMC 5447095. PMID 28611661.
Brown MJ (October 2009). "Success and failure of vaccines against renin-angiotensin system components". Nature Reviews. Cardiology. 6 (10): 639–47. doi:10.1038/nrcardio.2009.156. PMID 19707182. S2CID 15949.
Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, et al. (June 2020). "Withdrawal of antihypertensive drugs in older people". The Cochrane Database of Systematic Reviews. 2020 (6): CD012572. doi:10.1002/14651858.cd012572.pub2. PMC 7387859. PMID 32519776.

handle.net

hdl.handle.net

Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. (June 2004). "Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial". Lancet. 363 (9426): 2022–31. doi:10.1016/S0140-6736(04)16451-9. hdl:11392/462725. PMID 15207952. S2CID 19111421.
Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. (February 2003). "A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly" (PDF). The New England Journal of Medicine. 348 (7): 583–92. doi:10.1056/NEJMoa021716. hdl:2440/4230. PMID 12584366.

lecturio.com

Oiseth S, Jones L, Maza E (eds.). "Hyperaldosteronism". The Lecturio Medical Concept Library. Retrieved 25 July 2021.

mayoclinic.org

"High blood pressure (hypertension) - Uses for ACE inhibitors". Mayo Clinic. Archived from the original on 2016-08-01. Retrieved 2016-07-27. Page updated: June 29, 2016

merck.com

"Section 11. Cardiovascular Disorders – Chapter 85. Hypertension". Merck Manual of Geriatrics. July 2005. Archived from the original on 2009-01-23.

nelm.nhs.uk

Ladva S (2006-06-28). "NICE and BHS launch updated hypertension guideline". National Institute for Health and Clinical Excellence. Archived from the original on 2007-09-29. Retrieved 2006-09-30.

nice.org.uk

"Hypertension: Management of hypertension in adults in primary care | Guidance | NICE" (PDF). 28 June 2006. Archived (PDF) from the original on 2012-01-07. Retrieved 2012-01-09., p19
"Hypertension: management of hypertension in adults in primary care". National Institute for Health and Clinical Excellence. Archived from the original (PDF) on 2007-02-16. Retrieved 2006-09-30.
"CG34 Hypertension – quick reference guide" (PDF). National Institute for Health and Clinical Excellence. 28 June 2006. Archived from the original (PDF) on 13 March 2009. Retrieved 2009-03-04.

nih.gov

pubmed.ncbi.nlm.nih.gov

Law M, Wald N, Morris J (2003). "Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy". Health Technology Assessment. 7 (31): 1–94. doi:10.3310/hta7310. PMID 14604498.
Nelson MR, McNeil JJ, Peeters A, Reid CM, Krum H (June 2001). "PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998". The Medical Journal of Australia. 174 (11): 565–8. doi:10.5694/j.1326-5377.2001.tb143436.x. PMID 11453328. S2CID 204078909.
Wright JM, Musini VM, Gill R (April 2018). Wright JM (ed.). "First-line drugs for hypertension". The Cochrane Database of Systematic Reviews. 2018 (4): CD001841. doi:10.1002/14651858.CD001841.pub3. PMC 6513559. PMID 29667175.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. (February 2014). "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID 24352797.
Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL (August 2006). "Thiazide diuretics, potassium, and the development of diabetes: a quantitative review". Hypertension. 48 (2): 219–24. doi:10.1161/01.HYP.0000231552.10054.aa. PMID 16801488.
Wang TJ, Ausiello JC, Stafford RS (April 1999). "Trends in antihypertensive drug advertising, 1985-1996". Circulation. 99 (15): 2055–7. doi:10.1161/01.CIR.99.15.2055. PMID 10209012.
Heran BS, Chen JM, Wang JJ, Wright JM, et al. (Cochrane Hypertension Group) (November 2012). "Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension". The Cochrane Database of Systematic Reviews. 11: CD008167. doi:10.1002/14651858.CD008167.pub3. PMID 23152254.
Elliott WJ, Ram CV (September 2011). "Calcium channel blockers". Journal of Clinical Hypertension. 13 (9): 687–689. doi:10.1111/j.1751-7176.2011.00513.x. PMC 8108866. PMID 21896151.
"Calcium Channel Blockers". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. 2012. PMID 31643892. Retrieved 2023-12-22.
Bakris GL, Weir MR, Secic M, Campbell B, Weis-McNulty A (June 2004). "Differential effects of calcium antagonist subclasses on markers of nephropathy progression". Kidney International. 65 (6): 1991–2002. doi:10.1111/j.1523-1755.2004.00620.x. PMID 15149313.
Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, et al. (October 2013). "Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis". BMJ. 347: f6008. doi:10.1136/bmj.f6008. PMC 3807847. PMID 24157497.
Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. (November 2002). "Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial". JAMA. 288 (19): 2421–31. doi:10.1001/jama.288.19.2421. PMID 12435255.
Furberg CD, Wright Jr JT, Davis BR, Cutler JA, Alderman M, Black H, et al. (The Allhat Officers And Coordinators For The Allhat Collaborative Research Group) (December 2002). "Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)". JAMA. 288 (23): 2981–97. doi:10.1001/jama.288.23.2981. PMID 12479763.
Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, et al. (September 2006). "Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial". Hypertension. 48 (3): 374–84. doi:10.1161/01.HYP.0000231662.77359.de. PMID 16864749.
Borghi C, Soldati M, Bragagni A, Cicero AF (December 2020). "Safety implications of combining ACE inhibitors with thiazides for the treatment of hypertensive patients". Expert Opinion on Drug Safety. 19 (12): 1577–1583. doi:10.1080/14740338.2020.1836151. PMID 33047990. S2CID 222320206.
Barreras A, Gurk-Turner C (January 2003). "Angiotensin II receptor blockers". Proceedings. 16 (1): 123–126. doi:10.1080/08998280.2003.11927893. PMC 1200815. PMID 16278727.
Verma S, Strauss M (November 2004). "Angiotensin receptor blockers and myocardial infarction". BMJ. 329 (7477): 1248–9. doi:10.1136/bmj.329.7477.1248. PMC 534428. PMID 15564232.
Strauss MH, Hall AS (August 2006). "Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox". Circulation. 114 (8): 838–54. doi:10.1161/CIRCULATIONAHA.105.594986. PMID 16923768.
Tsuyuki RT, McDonald MA (August 2006). "Angiotensin receptor blockers do not increase risk of myocardial infarction". Circulation. 114 (8): 855–60. doi:10.1161/CIRCULATIONAHA.105.594978. PMID 16923769.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. (June 2004). "Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial". Lancet. 363 (9426): 2022–31. doi:10.1016/S0140-6736(04)16451-9. hdl:11392/462725. PMID 15207952. S2CID 19111421.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, et al. (September 2003). "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial". Lancet. 362 (9386): 772–6. doi:10.1016/S0140-6736(03)14284-5. PMID 13678870. S2CID 5650345.
Levy BI (September 2005). "How to explain the differences between renin angiotensin system modulators". American Journal of Hypertension. 18 (9 Pt 2): 134S–141S. doi:10.1016/j.amjhyper.2005.05.005. PMID 16125050.
Lévy BI (January 2004). "Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system". Circulation. 109 (1): 8–13. doi:10.1161/01.CIR.0000096609.73772.C5. PMID 14707017.
Reudelhuber TL (December 2005). "The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous". Hypertension. 46 (6): 1261–2. doi:10.1161/01.HYP.0000193498.07087.83. PMID 16286568.
Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN (August 1991). "Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure". The New England Journal of Medicine. 325 (5): 293–302. doi:10.1056/nejm199108013250501. PMID 2057034.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. (September 2016). "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America". Circulation. 134 (13): e282-93. doi:10.1161/CIR.0000000000000435. PMID 27208050.
Li EC, Heran BS, Wright JM (August 2014). "Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension". The Cochrane Database of Systematic Reviews. 2014 (8): CD009096. doi:10.1002/14651858.CD009096.pub2. PMC 6486121. PMID 25148386.
Farzam K, Jan A (2023), "Beta Blockers", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30422501, retrieved 2024-01-21
Nachawati D, Patel JB (2023). "Alpha-Blockers". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32310526. Retrieved 2024-01-21.
Lindholm LH, Carlberg B, Samuelsson O (29 Oct – 4 Nov 2005). "Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis". Lancet. 366 (9496): 1545–53. doi:10.1016/S0140-6736(05)67573-3. PMID 16257341. S2CID 34364430.
Carlberg B, Samuelsson O, Lindholm LH (6–12 Nov 2004). "Atenolol in hypertension: is it a wise choice?". Lancet. 364 (9446): 1684–9. doi:10.1016/S0140-6736(04)17355-8. PMID 15530629. S2CID 23759357.
Freemantle N, Cleland J, Young P, Mason J, Harrison J (June 1999). "beta Blockade after myocardial infarction: systematic review and meta regression analysis". BMJ. 318 (7200): 1730–7. doi:10.1136/bmj.318.7200.1730. PMC 31101. PMID 10381708.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (September 2003). "Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)". Hypertension. 42 (3): 239–46. doi:10.1161/01.HYP.0000086521.95630.5A. PMID 12925554.
Hariri L, Patel JB (2024). "Vasodilators". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32119310. Retrieved 2024-03-16.
Varon J, Marik PE (July 2000). "The diagnosis and management of hypertensive crises". Chest. 118 (1): 214–27. doi:10.1378/chest.118.1.214. PMID 10893382.
Craft J (April 2004). "Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure". Proceedings. 17 (2): 217–220. doi:10.1080/08998280.2004.11927973. PMC 1200656. PMID 16200104.
Patibandla S, Heaton J, Kyaw H (2024). "Spironolactone". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32119308. Retrieved 2024-03-16.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. (May 2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.
Giovannitti JA, Thoms SM, Crawford JJ (2015). "Alpha-2 adrenergic receptor agonists: a review of current clinical applications". Anesthesia Progress. 62 (1): 31–39. doi:10.2344/0003-3006-62.1.31. PMC 4389556. PMID 25849473.
Valerio CJ, Coghlan JG (August 2009). "Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient". Vascular Health and Risk Management. 5: 607–619. doi:10.2147/VHRM.S4713. PMC 2725793. PMID 19688101.
Neurath Jr HM, Goldman AI, Lavin MA, Schnaper HW, Fitz AE, Frohlich ED, et al. (Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension) (1978). "Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension". Annals of the New York Academy of Sciences. 304: 267–292. doi:10.1111/j.1749-6632.1978.tb25604.x. PMID 360921. S2CID 40939559.
Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. (February 2003). "A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly" (PDF). The New England Journal of Medicine. 348 (7): 583–92. doi:10.1056/NEJMoa021716. hdl:2440/4230. PMID 12584366.
Whelton PK, Williams B (November 2018). "The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: More Similar Than Different". JAMA. 320 (17): 1749–1750. doi:10.1001/jama.2018.16755. PMID 30398611. S2CID 53207044.
Lewis PJ, Kohner EM, Petrie A, Dollery CT (March 1976). "Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment". Lancet. 1 (7959): 564–6. doi:10.1016/S0140-6736(76)90359-7. PMID 55840. S2CID 20976708.
Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT (December 1982). "Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up". Lancet. 2 (8311): 1293–5. doi:10.1016/S0140-6736(82)91506-9. PMID 6128594. S2CID 43027989.
Messerli FH, Williams B, Ritz E (August 2007). "Essential hypertension". Lancet. 370 (9587): 591–603. doi:10.1016/S0140-6736(07)61299-9. PMID 17707755. S2CID 26414121.
Williams B (November 2003). "Treatment of hypertension in the UK: simple as ABCD?". Journal of the Royal Society of Medicine. 96 (11): 521–2. doi:10.1177/014107680309601101. PMC 539621. PMID 14594956.
Parekh N, Page A, Ali K, Davies K, Rajkumar C (April 2017). "A practical approach to the pharmacological management of hypertension in older people". Therapeutic Advances in Drug Safety. 8 (4): 117–132. doi:10.1177/2042098616682721. PMC 5394506. PMID 28439398.
Tatu AL, Elisei AM, Chioncel V, Miulescu M, Nwabudike LC (August 2019). "Immunologic adverse reactions of β-blockers and the skin". Experimental and Therapeutic Medicine. 18 (2): 955–959. doi:10.3892/etm.2019.7504. PMC 6639944. PMID 31384329. S2CID 145847997.
Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C (October 2016). "Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel". Internal Medicine Journal. 46 (10): 1189–1197. doi:10.1111/imj.13215. PMC 5129475. PMID 27527376.
Würzner G, Gerster JC, Chiolero A, Maillard M, Fallab-Stubi CL, Brunner HR, et al. (October 2001). "Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout". Journal of Hypertension. 19 (10): 1855–1860. doi:10.1097/00004872-200110000-00021. PMID 11593107. S2CID 20842819.
Worcester EM, Coe FL: Clinical practice. Calcium kidney stones" N Engl J Med 2010;363(10) 954-963. Worcester EM, Coe FL (September 2010). "Clinical practice. Calcium kidney stones". The New England Journal of Medicine. 363 (10): 954–63. doi:10.1056/NEJMcp1001011. PMC 3192488. PMID 20818905.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. (May 2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report" (PDF). JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Archived (PDF) from the original on 2013-02-16. Retrieved 2013-02-17.
Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL, et al. (May 2007). "Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention". Circulation. 115 (21): 2761–88. doi:10.1161/circulationaha.107.183885. PMID 17502569.
Pietropaoli D, Del Pinto R, Ferri C, Wright JT, Giannoni M, Ortu E, et al. (December 2018). "Poor Oral Health and Blood Pressure Control Among US Hypertensive Adults". Hypertension. 72 (6): 1365–1373. doi:10.1161/HYPERTENSIONAHA.118.11528. PMID 30540406.
Papadopoulou Z, Tsialiou TM, Styanidou FE, Kavvadas D, Papamitsou T (December 2021). "In Utero Exposure to Antihypertensive Medication during the First Trimester: Is the Risk Worth Taking?". Acta Medica Academica. 50 (3): 372–381. doi:10.5644/ama2006-124.356. PMID 35164513. S2CID 246826268.
Whybrow R, Sandall J, Girling J, Brown H, Seed PT, Green M, et al. (December 2022). "Implementation of a novel shared decision-making intervention in women with chronic hypertension in pregnancy: multiple-site multiple-method investigation". Pregnancy Hypertension. 30: 137–144. doi:10.1016/j.preghy.2022.09.007. PMID 36194966. S2CID 252414448.
Godfraind T (2017-05-29). "Discovery and Development of Calcium Channel Blockers". Frontiers in Pharmacology. 8: 286. doi:10.3389/fphar.2017.00286. PMC 5447095. PMID 28611661.
Brown MJ (October 2009). "Success and failure of vaccines against renin-angiotensin system components". Nature Reviews. Cardiology. 6 (10): 639–47. doi:10.1038/nrcardio.2009.156. PMID 19707182. S2CID 15949.
Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, et al. (June 2020). "Withdrawal of antihypertensive drugs in older people". The Cochrane Database of Systematic Reviews. 2020 (6): CD012572. doi:10.1002/14651858.cd012572.pub2. PMC 7387859. PMID 32519776.

ncbi.nlm.nih.gov

Wright JM, Musini VM, Gill R (April 2018). Wright JM (ed.). "First-line drugs for hypertension". The Cochrane Database of Systematic Reviews. 2018 (4): CD001841. doi:10.1002/14651858.CD001841.pub3. PMC 6513559. PMID 29667175.
Elliott WJ, Ram CV (September 2011). "Calcium channel blockers". Journal of Clinical Hypertension. 13 (9): 687–689. doi:10.1111/j.1751-7176.2011.00513.x. PMC 8108866. PMID 21896151.
"Calcium Channel Blockers". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. 2012. PMID 31643892. Retrieved 2023-12-22.
Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, et al. (October 2013). "Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis". BMJ. 347: f6008. doi:10.1136/bmj.f6008. PMC 3807847. PMID 24157497.
Barreras A, Gurk-Turner C (January 2003). "Angiotensin II receptor blockers". Proceedings. 16 (1): 123–126. doi:10.1080/08998280.2003.11927893. PMC 1200815. PMID 16278727.
Verma S, Strauss M (November 2004). "Angiotensin receptor blockers and myocardial infarction". BMJ. 329 (7477): 1248–9. doi:10.1136/bmj.329.7477.1248. PMC 534428. PMID 15564232.
Li EC, Heran BS, Wright JM (August 2014). "Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension". The Cochrane Database of Systematic Reviews. 2014 (8): CD009096. doi:10.1002/14651858.CD009096.pub2. PMC 6486121. PMID 25148386.
Farzam K, Jan A (2023), "Beta Blockers", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30422501, retrieved 2024-01-21
Nachawati D, Patel JB (2023). "Alpha-Blockers". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32310526. Retrieved 2024-01-21.
Freemantle N, Cleland J, Young P, Mason J, Harrison J (June 1999). "beta Blockade after myocardial infarction: systematic review and meta regression analysis". BMJ. 318 (7200): 1730–7. doi:10.1136/bmj.318.7200.1730. PMC 31101. PMID 10381708.
Hariri L, Patel JB (2024). "Vasodilators". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32119310. Retrieved 2024-03-16.
Craft J (April 2004). "Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure". Proceedings. 17 (2): 217–220. doi:10.1080/08998280.2004.11927973. PMC 1200656. PMID 16200104.
Patibandla S, Heaton J, Kyaw H (2024). "Spironolactone". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32119308. Retrieved 2024-03-16.
Giovannitti JA, Thoms SM, Crawford JJ (2015). "Alpha-2 adrenergic receptor agonists: a review of current clinical applications". Anesthesia Progress. 62 (1): 31–39. doi:10.2344/0003-3006-62.1.31. PMC 4389556. PMID 25849473.
Valerio CJ, Coghlan JG (August 2009). "Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient". Vascular Health and Risk Management. 5: 607–619. doi:10.2147/VHRM.S4713. PMC 2725793. PMID 19688101.
Williams B (November 2003). "Treatment of hypertension in the UK: simple as ABCD?". Journal of the Royal Society of Medicine. 96 (11): 521–2. doi:10.1177/014107680309601101. PMC 539621. PMID 14594956.
Parekh N, Page A, Ali K, Davies K, Rajkumar C (April 2017). "A practical approach to the pharmacological management of hypertension in older people". Therapeutic Advances in Drug Safety. 8 (4): 117–132. doi:10.1177/2042098616682721. PMC 5394506. PMID 28439398.
Tatu AL, Elisei AM, Chioncel V, Miulescu M, Nwabudike LC (August 2019). "Immunologic adverse reactions of β-blockers and the skin". Experimental and Therapeutic Medicine. 18 (2): 955–959. doi:10.3892/etm.2019.7504. PMC 6639944. PMID 31384329. S2CID 145847997.
Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C (October 2016). "Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel". Internal Medicine Journal. 46 (10): 1189–1197. doi:10.1111/imj.13215. PMC 5129475. PMID 27527376.
Worcester EM, Coe FL: Clinical practice. Calcium kidney stones" N Engl J Med 2010;363(10) 954-963. Worcester EM, Coe FL (September 2010). "Clinical practice. Calcium kidney stones". The New England Journal of Medicine. 363 (10): 954–63. doi:10.1056/NEJMcp1001011. PMC 3192488. PMID 20818905.
Godfraind T (2017-05-29). "Discovery and Development of Calcium Channel Blockers". Frontiers in Pharmacology. 8: 286. doi:10.3389/fphar.2017.00286. PMC 5447095. PMID 28611661.
Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, et al. (June 2020). "Withdrawal of antihypertensive drugs in older people". The Cochrane Database of Systematic Reviews. 2020 (6): CD012572. doi:10.1002/14651858.cd012572.pub2. PMC 7387859. PMID 32519776.

meshb.nlm.nih.gov

Antihypertensive+Agents at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

nhlbi.nih.gov

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. (May 2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report" (PDF). JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Archived (PDF) from the original on 2013-02-16. Retrieved 2013-02-17.

profiles.nlm.nih.gov

Freis ED (1995). "Historical Development of Antihypertensive Treatment" (PDF). In Laragh JM, Brenner BM (eds.). Hyperlension: Pathophysiology, Diagnosis, and Management (Second ed.). New York: Raven Press, Ltd. pp. 2741–5. Archived from the original (PDF) on 2017-02-22.

nihr.ac.uk

evidence.nihr.ac.uk

"Decision aid helps pregnant women with high blood pressure". NIHR Evidence. 15 February 2023. doi:10.3310/nihrevidence_56796. S2CID 257843687.

pharmaxchange.info

Mehta A (January 1, 2011). "Direct Renin Inhibitors as Antihypertensive Drugs". Archived from the original on 21 February 2014. Retrieved 6 February 2014.

sciencedirect.com

Spiller HA (January 2005). "ACE Inhibitors". In Wexler P (ed.). Encyclopedia of Toxicology (Second ed.). New York: Elsevier. pp. 9–11. doi:10.1016/b0-12-369400-0/00006-5. ISBN 978-0-12-369400-3. Retrieved 2024-03-13.

semanticscholar.org

api.semanticscholar.org

Nelson MR, McNeil JJ, Peeters A, Reid CM, Krum H (June 2001). "PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998". The Medical Journal of Australia. 174 (11): 565–8. doi:10.5694/j.1326-5377.2001.tb143436.x. PMID 11453328. S2CID 204078909.
Borghi C, Soldati M, Bragagni A, Cicero AF (December 2020). "Safety implications of combining ACE inhibitors with thiazides for the treatment of hypertensive patients". Expert Opinion on Drug Safety. 19 (12): 1577–1583. doi:10.1080/14740338.2020.1836151. PMID 33047990. S2CID 222320206.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. (June 2004). "Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial". Lancet. 363 (9426): 2022–31. doi:10.1016/S0140-6736(04)16451-9. hdl:11392/462725. PMID 15207952. S2CID 19111421.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, et al. (September 2003). "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial". Lancet. 362 (9386): 772–6. doi:10.1016/S0140-6736(03)14284-5. PMID 13678870. S2CID 5650345.
Lindholm LH, Carlberg B, Samuelsson O (29 Oct – 4 Nov 2005). "Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis". Lancet. 366 (9496): 1545–53. doi:10.1016/S0140-6736(05)67573-3. PMID 16257341. S2CID 34364430.
Carlberg B, Samuelsson O, Lindholm LH (6–12 Nov 2004). "Atenolol in hypertension: is it a wise choice?". Lancet. 364 (9446): 1684–9. doi:10.1016/S0140-6736(04)17355-8. PMID 15530629. S2CID 23759357.
Neurath Jr HM, Goldman AI, Lavin MA, Schnaper HW, Fitz AE, Frohlich ED, et al. (Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension) (1978). "Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension". Annals of the New York Academy of Sciences. 304: 267–292. doi:10.1111/j.1749-6632.1978.tb25604.x. PMID 360921. S2CID 40939559.
Whelton PK, Williams B (November 2018). "The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: More Similar Than Different". JAMA. 320 (17): 1749–1750. doi:10.1001/jama.2018.16755. PMID 30398611. S2CID 53207044.
Lewis PJ, Kohner EM, Petrie A, Dollery CT (March 1976). "Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment". Lancet. 1 (7959): 564–6. doi:10.1016/S0140-6736(76)90359-7. PMID 55840. S2CID 20976708.
Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT (December 1982). "Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up". Lancet. 2 (8311): 1293–5. doi:10.1016/S0140-6736(82)91506-9. PMID 6128594. S2CID 43027989.
Messerli FH, Williams B, Ritz E (August 2007). "Essential hypertension". Lancet. 370 (9587): 591–603. doi:10.1016/S0140-6736(07)61299-9. PMID 17707755. S2CID 26414121.
Tatu AL, Elisei AM, Chioncel V, Miulescu M, Nwabudike LC (August 2019). "Immunologic adverse reactions of β-blockers and the skin". Experimental and Therapeutic Medicine. 18 (2): 955–959. doi:10.3892/etm.2019.7504. PMC 6639944. PMID 31384329. S2CID 145847997.
Würzner G, Gerster JC, Chiolero A, Maillard M, Fallab-Stubi CL, Brunner HR, et al. (October 2001). "Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout". Journal of Hypertension. 19 (10): 1855–1860. doi:10.1097/00004872-200110000-00021. PMID 11593107. S2CID 20842819.
Papadopoulou Z, Tsialiou TM, Styanidou FE, Kavvadas D, Papamitsou T (December 2021). "In Utero Exposure to Antihypertensive Medication during the First Trimester: Is the Risk Worth Taking?". Acta Medica Academica. 50 (3): 372–381. doi:10.5644/ama2006-124.356. PMID 35164513. S2CID 246826268.
"Decision aid helps pregnant women with high blood pressure". NIHR Evidence. 15 February 2023. doi:10.3310/nihrevidence_56796. S2CID 257843687.
Whybrow R, Sandall J, Girling J, Brown H, Seed PT, Green M, et al. (December 2022). "Implementation of a novel shared decision-making intervention in women with chronic hypertension in pregnancy: multiple-site multiple-method investigation". Pregnancy Hypertension. 30: 137–144. doi:10.1016/j.preghy.2022.09.007. PMID 36194966. S2CID 252414448.
Brown MJ (October 2009). "Success and failure of vaccines against renin-angiotensin system components". Nature Reviews. Cardiology. 6 (10): 639–47. doi:10.1038/nrcardio.2009.156. PMID 19707182. S2CID 15949.

umaryland.edu

blogs.pharmacy.umaryland.edu

Watson K (18 May 2016). "Which Thiazide-Type Diuretic Should be First-Line in Patients with Hypertension?". University of Maryland School of Pharmacy.

uq.edu.au

espace.library.uq.edu.au

Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. (February 2003). "A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly" (PDF). The New England Journal of Medicine. 348 (7): 583–92. doi:10.1056/NEJMoa021716. hdl:2440/4230. PMID 12584366.

web.archive.org

Nelson M. "Drug treatment of elevated blood pressure". Australian Prescriber (33): 108–112. Archived from the original on 26 August 2010. Retrieved August 11, 2010.
"Hypertension: Management of hypertension in adults in primary care | Guidance | NICE" (PDF). 28 June 2006. Archived (PDF) from the original on 2012-01-07. Retrieved 2012-01-09., p19
"High blood pressure (hypertension) - Uses for ACE inhibitors". Mayo Clinic. Archived from the original on 2016-08-01. Retrieved 2016-07-27. Page updated: June 29, 2016
"Hypertension: management of hypertension in adults in primary care". National Institute for Health and Clinical Excellence. Archived from the original (PDF) on 2007-02-16. Retrieved 2006-09-30.
Ladva S (2006-06-28). "NICE and BHS launch updated hypertension guideline". National Institute for Health and Clinical Excellence. Archived from the original on 2007-09-29. Retrieved 2006-09-30.
Mehta A (January 1, 2011). "Direct Renin Inhibitors as Antihypertensive Drugs". Archived from the original on 21 February 2014. Retrieved 6 February 2014.
"Section 11. Cardiovascular Disorders – Chapter 85. Hypertension". Merck Manual of Geriatrics. July 2005. Archived from the original on 2009-01-23.
"CG34 Hypertension – quick reference guide" (PDF). National Institute for Health and Clinical Excellence. 28 June 2006. Archived from the original (PDF) on 13 March 2009. Retrieved 2009-03-04.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. (May 2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report" (PDF). JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Archived (PDF) from the original on 2013-02-16. Retrieved 2013-02-17.
Freis ED (1995). "Historical Development of Antihypertensive Treatment" (PDF). In Laragh JM, Brenner BM (eds.). Hyperlension: Pathophysiology, Diagnosis, and Management (Second ed.). New York: Raven Press, Ltd. pp. 2741–5. Archived from the original (PDF) on 2017-02-22.